Tsai, Chi-Hao <br/><br/>
Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions.  [electronic resource] 

 -  Biochimica et biophysica acta. Molecular cell research  02 2020 
 - 118564 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2596 
<br/><br/><label>Standard No.: </label>10.1016/j.bbamcr.2019.118564  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation--drug effects<br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Histone Deacetylase Inhibitors--chemistry<br/>Histone Deacetylases--metabolism<br/>Humans<br/>Phosphorylation--drug effects<br/>Protein Binding<br/>Protein Kinase C-alpha--metabolism<br/>RNA Interference<br/>RNA, Small Interfering--metabolism<br/>Receptors, Aryl Hydrocarbon--antagonists & inhibitors<br/>Stomach Neoplasms--metabolism<br/>Up-Regulation--drug effects